Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
The Lancet Regional Health. Western Pacific|December 9, 2021
Immunogenicity and safety of inactivated enterovirus A71 vaccines in children aged 6-35 months in China: a non-inferiority, randomised controlled trialYan Li, Fan Gao, Yamin Wang, et al.
Emerging Infectious Diseases|April 19, 2017
Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, ChinaFuqiang Cui, Lipin Shen, Li Li, et al.
BMC Public Health|December 5, 2025
WSK-V102C COVID-19 vaccine effectiveness against SARS-CoV-2 JN.1 symptomatic infection among adults 60 years and older: a prospective observational cohort study in Shaanxi Province, China, 2024Lin Tang, Weijun Hu, Yajun Li, et al.
Hepatology (Baltimore, Md.)|June 28, 2020
Changing Epidemiology of Hepatitis A in China: Evidence From Three National Serological Surveys and the National Notifiable Disease Reporting SystemFuzhen Wang, Xiaojin Sun, Feng Wang, et al.
Vaccine: X|January 14, 2025
A discrete choice experiment on Chinese parents' preferences of vaccine schedules against six childhood infectious diseasesAodi Huang, Lin Tang, Lifang Huang, et al.
China CDC Weekly|May 17, 2023
Effectiveness of DTaP Against Pertussis in ≤2-Year-Old Children - Linyi Prefecture, Shandong Province, China, 2017-2019Pinpin Zhu, Dan Wu, Yan Wang, et al.
Vaccines|July 27, 2024
Safety, Immunogenicity, and Effectiveness of Chinese-Made COVID-19 Vaccines in the Real World: An Interim Report of a Living Systematic ReviewYangyang Qi, Hui Zheng, Jinxia Wang, et al.
China CDC Weekly|May 13, 2024
Thirty Years of Experience of Acute Flaccid Paralysis Surveillance for Polio - China, 1993-2022Hong Yang, Ning Wen, Chunxiang Fan, et al.
Vaccines|February 28, 2023
Effectiveness of Inactivated COVID-19 Vaccines against Delta-Variant COVID-19: Evidence from an Outbreak in Inner Mongolia Autonomous Region, ChinaChao Ma, Chang Huang, Wenrui Wang, et al.
Human Vaccines & Immunotherapeutics|April 15, 2024
Acceptance and willingness to pay for DTaP-HBV-IPV-Hib hexavalent vaccine among parents: A cross-sectional survey in ChinaAodi Huang, Xia Xu, Lin Tang, et al.
Pageof 10